Sound advice for diagnosing respiratory disease

Diagnosing respiratory disease during telehealth consults can be challenging as clinicians can’t use their standard tools, typically a stethoscope, chest x-ray or spirometer, for evaluating acute respiratory symptoms.

Designed for telehealth, ResAppDx is an app-based, remote test for patients who present with respiratory symptoms. Validated in large Australian clinical studies, ResAppDx uses AI algorithms to listen for unique features in cough sounds to indicate the presence of lower respiratory tract disease, pneumonia, asthma/reactive airway disease exacerbations, COPD exacerbations, bronchiolitis and croup.

For example, if a patient presents with a cough and fever during a telehealth consultation, without a stethoscope, it is difficult to identify lung sounds typically associated with pneumonia. By analysing the patient’s cough, ResAppDx is able to identify these sounds and assist in making the correct diagnosis, increasing confidence in treatment decisions. ResAppDx has now been approved by the TGA for ARTG listing as a class IIa medical device.

When requested by their clinician, the patient simply downloads the app on their own phone to capture five cough sounds and the test result is instantly sent to their doctor. No additional equipment or physical contact is necessary, reducing the spread of infection.